Jamie Lee Bigley, OTR/L | |
1525 W Frye Rd, Chandler, AZ 85224-6178 | |
(480) 812-7000 | |
Not Available |
Full Name | Jamie Lee Bigley |
---|---|
Gender | Female |
Speciality | Occupational Therapist |
Location | 1525 W Frye Rd, Chandler, Arizona |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1609166206 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225X00000X | Occupational Therapist | 4803 (Arizona) | Primary |
Provider Name | Theraplay4kidz, Llc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1750727798 PECOS PAC ID: 3476823972 Enrollment ID: O20190321000727 |
News Archive
It's rare for scientists to get what they describe as "clean" results without spending a lot of time repeating the same experiment over and over again. But when researchers saw the mice they were working with doubling their weight within a month or two, they knew they were on to something.
Infants who are exposed to television and video in low socio-economic households tend to have limited verbal interactions with their mothers, according to a new study led by Alan L. Mendelsohn, MD, Assistant Professor of Pediatrics and Director of Clinical Research for the divisions of General and Developmental-Behavioral Pediatrics in the Department of Pediatrics at NYU School of Medicine.
Researchers from the University of Pennsylvania's Abramson Cancer Center have developed two experimental immunotherapy methods that include one chimeric antigen receptor (CAR) T cell therapy for the treatment of multiple myeloma patients who were not responding to other treatments.
IDEV Technologies, Incorporated, (IDEV) an emerging leader in the development and marketing of minimally invasive medical technologies, today announced the European launch of the SUPERA VERITAS™ Peripheral Vascular System, a novel and innovative stent delivery system designed to be reliable, easy to use and precise. The SUPERA VERITAS system was formally launched in the first quarter of 2010 at the Leipzig Interventional Course (LINC) 2010 conference in Leipzig, Germany.
AVANIR Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced the submission of its Complete Response to the October 2006 Approvable Letter issued by the U.S. Food and Drug Administration (FDA) for Zenvia™ (dextromethorphan/quinidine) for the treatment of pseudobulbar affect (PBA). AVANIR expects the FDA to classify the response as a Class 2 resubmission, which would result in an expected review period of 180 days and potential approval of Zenvia in the fourth calendar quarter of 2010.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Jamie Lee Bigley, OTR/L 1525 W Frye Rd, Chandler, AZ 85224-6178 Ph: (480) 812-7000 | Jamie Lee Bigley, OTR/L 1525 W Frye Rd, Chandler, AZ 85224-6178 Ph: (480) 812-7000 |
News Archive
It's rare for scientists to get what they describe as "clean" results without spending a lot of time repeating the same experiment over and over again. But when researchers saw the mice they were working with doubling their weight within a month or two, they knew they were on to something.
Infants who are exposed to television and video in low socio-economic households tend to have limited verbal interactions with their mothers, according to a new study led by Alan L. Mendelsohn, MD, Assistant Professor of Pediatrics and Director of Clinical Research for the divisions of General and Developmental-Behavioral Pediatrics in the Department of Pediatrics at NYU School of Medicine.
Researchers from the University of Pennsylvania's Abramson Cancer Center have developed two experimental immunotherapy methods that include one chimeric antigen receptor (CAR) T cell therapy for the treatment of multiple myeloma patients who were not responding to other treatments.
IDEV Technologies, Incorporated, (IDEV) an emerging leader in the development and marketing of minimally invasive medical technologies, today announced the European launch of the SUPERA VERITAS™ Peripheral Vascular System, a novel and innovative stent delivery system designed to be reliable, easy to use and precise. The SUPERA VERITAS system was formally launched in the first quarter of 2010 at the Leipzig Interventional Course (LINC) 2010 conference in Leipzig, Germany.
AVANIR Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced the submission of its Complete Response to the October 2006 Approvable Letter issued by the U.S. Food and Drug Administration (FDA) for Zenvia™ (dextromethorphan/quinidine) for the treatment of pseudobulbar affect (PBA). AVANIR expects the FDA to classify the response as a Class 2 resubmission, which would result in an expected review period of 180 days and potential approval of Zenvia in the fourth calendar quarter of 2010.
› Verified 2 days ago
Sarah J. Whitney, MSOTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 575 W Pecos Rd Apt 1127, Chandler, AZ 85225 Phone: 602-793-1492 | |
Taylor Knoll, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3160 N Arizona Ave Ste 105, Chandler, AZ 85225 Phone: 480-365-9981 | |
Kendra Alaine Bauman, O.T. Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1525 W Frye Rd, Chandler, AZ 85224 Phone: 480-812-7000 | |
Mrs. Carole Beth Gates, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 6283 W Megan St, Chandler, AZ 85226 Phone: 480-634-4993 | |
Kylie Metherd, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2715 S Alma School Rd Ste 3, Chandler, AZ 85286 Phone: 480-508-5252 | |
Christine Rose Prigge, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 621 N Tercera Ave, Chandler, AZ 85226 Phone: 480-239-1595 Fax: 480-855-3507 | |
Amy Carr, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2175 N Alma School Rd Ste A106, Chandler, AZ 85224 Phone: 480-855-0474 |